The global Bacillus Coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Bacillus Coagulans is a type of live bacterial culture that can withstand stomach acid and digest easily in the intestines. It is commonly used as a probiotic supplement to support digestive and immune health. Bacillus Coagulans aids in balancing intestinal flora and regulating bowel movements. It produces lactic acid as a byproduct which decreases stomach pH and inhibits the growth of harmful bacteria. The probiotic properties make it suitable for nutritional supplements for digestive health, immune function, and weight management.
Market key trends:
One of the key trends in the Bacillus Coagulans market is the increasing consumer preference for natural and plant-based dietary supplements. The growth in health awareness has fueled the demand for probiotic supplements containing live bacteria cultures like Bacillus Coagulans that provide digestive support and immune benefits. Another trend is the expansion of application scope from dietary to clinical supplements. Ongoing research validating the therapeutic properties is supporting its use in therapeutic formulations for conditions like IBS, arthritis, and antiviral effects. Manufacturers are developing innovative delivery formats like gummies, chewable tablets to increase customer outreach.
Porter’s Analysis
Threat of new entrants: Low barriers means threat of new entrants is high. New players can easily enter this market with low investment required for production facilities and R&D.
Bargaining power of buyers: Buyers have high bargaining power due to availability of substitutes. Buyers can substitute one brand of Bacillus Coagulans with other easily available substitutes.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of substitutes of Bacillus Coagulans. Switching costs for buyers are low if one supplier demands higher prices.
Threat of new substitutes: Threat of substitutes is high as prebiotics and probiotics are available that can be used as alternatives.
Competitive rivalry: Industry faces high competition due to presence of many domestic and international players. pricing pressures exists due to presence of substitutes.
Key Takeaways
The global Bacillus Coagulans market size is expected to reach US$ 1.76 Bn by 2030, expanding at a CAGR of 6.8% over the forecast period. Growing awareness about digestive and gut health and rising cases of lifestyle diseases are supporting market growth.
Regionally, North America dominates the Bacillus Coagulans market and accounted for over 35% of global demand in 2023. Presence of major players and rising health consciousness among consumers in US and Canada is fueling market in the region. Asia Pacific is expected to exhibit fastest growth during the forecast period supported by rising disposable income, growing middle class population and their focus on preventive healthcare in countries such as India and China.
Key players operating in the Bacillus Coagulans market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech. These players are focusing on new product launches and strategic partnerships to enhance their market share. For instance, in 2020, Ganeden launched GanedenBC30 to strengthen its product portfolio.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
